As home to one in six persons on the planet, India is not just a land of opportunity for those eyeing its vast consumer class but also a huge captive market for healthcare. The sector comprising hospitals, medicines, devices, diagnostics and new age health-tech businesses is estimated to be growing a tad faster than the nominal growth of the economy and is projected to cross $300 billion by 2022.

Healthcare has been one of the few sectors that has been consistently showing up in the radar of both private investors as well as strategic acquirers. According to VCCEdge, the sector has consistently attracted $1-2 billion of private investment and $3-5 billion of M&As over the last several years.

While healthcare services have pulled in a good chunk of the PE money, drug makers have been the driving force for M&As, especially overseas deals to penetrate deeper into the regulated markets of US and Europe.

With a vast chunk of healthcare services still run by public institutions, the government has also been actively looking to up the game. It launched the world’s largest state funded healthcare scheme under Ayushman Bharat last September.

Its think-tank NITI Aayog also came out with a plan to create a national health stack and a national health register that seeks to maintain health records of citizens.

Although the projects face question marks related to data safety these could drive better outcomes for healthcare diagnosis and delivery while at the same time throwing up a new set of business opportunity, especially for tech firms.

On the one hand, this spells big business to be carved out by health entrepreneurs, it also brings major challenges given the widening demand supply gap and skills shortage besides the regulatory issues. In particular, the generics pharma giants have been facing regulatory baton in key overseas markets, the price capping in domestic market also affects the business strategy. Price control moves have also hit the healthcare delivery and medical device sector in the recent past.

To discuss the business opportunity and the emerging challenges, Mosaic Digital, the corporate banner behind VCCircle is organising its next edition of Healthcare Investment Summit on October 11 at Hotel ITC Grand Central in Mumbai.


October 11, 2019 | Mumbai
08:30 am - 09:30 am Registration & Networking

Venue: Pre-Function Area

09:30 am – 09:40 am Opening Address
09:40 am – 10:00 am Keynote Address



10:00 am – 10:40 am Panel Discussion I: New booster shot for drug makers

Indian pharma companies have taken big strides globally capitalising on the patent cliff. But that space is shrinking, and they now need new growth drivers. From a 3-7 years perspective where does the big opportunity lie- APIs or formulations? How should drug makers strategize to ride the wave while creating a more sustainable business model? Is niche and specialised drug discovery and delivery the new white space?

10:40 am – 11:00 am Fireside chat: Diagnostics
11:00 am – 11:40 am Panel Discussion II: High end diagnostics

Diagnostics has largely come to be associated with pathology chains. But there is a lot more going in the diagnostics world. While mass end diagnostics business will continue to dominate, what is the state of niche and high-end diagnostics field?

11:40 am – 12:00 pm Networking over Tea/Coffee

Venue: Pre-Function Area

12:00 pm – 12:30 pm Faceoff: Regional chains’ national claim

Large corporate hospital chains have seen a string of consolidation moves in the last two years. Although there is still scope of more activity to create pan-India healthcare chains, all eyes are now on the regional champions. Can they hold their nerves to expand outside their comfort zones and what could be the game plan in such cases? Would the larger national chains see acquisition of smaller hospital groups as the next growth driver?

12:30 pm – 01:10 pm Panel Discussion III: Inclusive health insurance

Ayushman Bharat opened up a new set of opportunity for health insurance as also the hospital chains. How can insurers create products to create better healthcare outcomes? Is there a scope for disruptive product development to cater to newer forms of delivery- be it healthcare at home, day-care procedures and even OPD claims?

01:10 pm - 02:10 pm Networking Lunch

Venue: Pre-Function Area

02:10 pm - 02:50 pm Panel Discussion IV: Digital transformation in healthcare

How are healthcare companies preparing their workforce for digitised health world? How are large med-tech companies using new technologies such as artificial intelligence, robotics and 3D printing to drive better solutions?

02:50 pm - 03:10 pm Special address: Health-tech
03:10 pm - 03:50 pm Panel Discussion V: Scale challenges in health-tech
03:50 pm - 04:10 pm Networking over Tea/Coffee

Venue: Pre-Function Area

04:10 pm - 05:00 pm Start-up Exchange: HealthTech. LIVE

A curated platform that brings together a set of handpicked innovative healthcare start-ups making an elevator pitch to select jury of angel investors & VCs.

05:00 pm Closing Remarks and End of Conference


A. Velumani

Creator and MD, Thyrocare

A visionary and an able business administrator, Dr. A. Velumani proves amply clearly to industry that, “Focus gives Success”. Born toa landless farmer in a small village near Coimbatore, South India, today he owns and operates Thyrocare, an industry leader and a brand worth over Rs. 3000 crores. Began as a mathematician, he acquired his Ph.D in Thyroid Biochemistry from BARC / Mumbai University. He worked for 14 years in BARC as a Research Scientist and Teacher and then became an administrator in business.

He is also MD of Nueclear Healthcare Limited which is a Radiology vertical. His focus areas are Thyroid Biochemistry, Bioanalytical Chemistry, Nuclear Chemistry and Nuclear Medicine.

An infectious motivator, he has succeeded in converting educated as employed, graduates as professionals, individuals as entrepreneurs, vendors as partners, family members as wealth creators and by his unique way, transformed intimidating problems into opportunities.

He is hilarious when it comes to educating and motivating youth in Entrepreneurship. 

Dr. Harish Pillai

CEO, Aster India Aster DM Healthcare

A doctor with exceptional leadership skills, Dr. Harish Pillai joined the Aster DM Healthcare Group as the CEO of Aster Medcity, Kochi in the year 2013. His ability to strategize and manage large-scale healthcare organisations helped Aster Medcity consolidate its place among the top hospitals in the country in a matter of just one year.

Subsequently, Dr. Harish Pillai was promoted as the Cluster Head of Aster DM Healthcare in Kerala and Hyderabad that included 5 hospitals. He was also responsible for commissioning the upcoming green-field projects of the group. In April 2018, Dr. Harish Pillai was promoted as the CEO of Aster India that is currently spread across 5 states and has 13 hospitals with around 4500 beds and 8 clinics.

An expert in hospital administration, quality, brand management, business strategy, product launches and joint ventures, Dr. Harish Pillai has played a significant role in the development of the healthcare industry in India and the Middle East & North Africa (MENA) by setting new benchmarks in quality and patient care.

Prior to joining Aster DM Healthcare, Dr. Harish Pillai was the CEO of Egypt’s biggest private tertiary care hospital - As Salam International Hospital, Cairo, for over 7 years. He has also been instrumental in implementing several high-value healthcare initiatives in Cairo.

One of the most influential leaders in the Indian healthcare industry, Dr. Harish Pillai is a Member of the Joint Commission International (JCI) Standards Advisory Panel; Member of Governance Council of Association of Healthcare Providers (AHPI); National Co- Chair for Medical Value Travel Committee in Federation of Indian Chambers of Commerce and Industry (FICCI); Elected secretary of the Kerala Medical Value Travel Society (KMVTS); visiting faculty at Tata Institute of Social Sciences (TISS) Mumbai and Administrative Staff College of India (ASCI) Hyderabad.

Dr. Harish Pillai has featured in the April 2018 Cover Story of Healthcare Radius Magazine and was conferred with a Special Jury Award for CEO of The Year at the 1st BW Healthcare Hospital Summit & Awards in May 2019.

Gaurav Agarwal

Co-founder, 1mg

Gaurav is the co-founder of 1mg, India's #1 Health platform. With over 18 million app downloads, and 160 million monthly Page Views, 1mg is the favorite app for health consumers across the country. Gaurav was born and raised in Kanpur.

He is a Computer Science graduate from Indian Institute of Technology-Delhi (IIT-D). Prior to 1mg, Gaurav was the Business Head at Zynga for its globally bestselling online social gaming business, Farmville.

Arunima Patel

Founder and MD, iGenetic Diagnostics

After completing her engineering degree in Electronics & Communications, Ms. Patel did MBA from Indian Institute of Management, Ahmedabad (IIMA).

She started her career with multinationals like Prudential Insurance and IBM. She then joined the healthcare investment team of private equity firm Actis where she was instrumental in Actis’s investment into Sterling Hospitals.

It was her stint at Actis that she realized the need and scope of molecular testing service, an activity that were at nascent stages in India then.

She then started iGenetic from scratch with a committed to provide quality diagnostics in Tier II and III cities and rural areas at affordable prices. She was instrumental in attracting investment from marquee investors such as Manipal Education & Medical Group and CDC which is UK Government’s private equity arm. Before MEMG and CDC, she raised Rs 6.5 crore from high net worth individuals.

Ms. Patel has been rightly selected by Forbes India to be one of the women power trailblazers for the year 2018.

In Near future, she plans to take iGenetic to greater heights and the company will continue setting new benchmarks in diagnosis of serious issues such as critical care infections, cancer, infertility, neurology and others. iGenetic is already earned the stature of being the only diagnostics company in India to that can deliver a septicemia (infection of the blood) test report within 24 hours. With a mission to touch a billion lives through the services of her company, Ms. Patel plans to take iGenetic’s presence to Sri Lanka, Middle East and other neighboring countries.

She is socially inclined and is personally contributing to several NGOs. Education in the country and skills are areas dear to her and she is involved with two foundations – Skills Foundation which is building and managing schools for remote areas in Bihar and Adharshilla which funds and manages schools in Madhya Pradesh.

When she is not working, she is globe-trotting being an avid traveler. She is also passionate about health and runs and cycles every day in her free time.

Zoya Brar

Founder and CEO, Core Diagnostics



  • *Offered Price +18% GST
  • Total no. of Seats

    Individual Ticket

  • INR 13,000
  • 1

    Gold Package

  • INR 36,000
  • 3

    Diamond Package

  • INR 55,000
  • 5

    Platinum Package

  • INR 70,000
  • 7

For any query, please reach us at register@vccircle.com, +91-9560888566 / +91-120-4171111

Cancellation Policy:

There is no cash refund in case you cancel the registration from your end. We will issue a credit note for an equivalent amount which you can adjust/utilise against any of our future events (under the validity period) if the registration is cancelled at least 3 days before the event, post which NO credit note will be issued. Company reserves the right to amend content, expert, policy, venue & date(s) of the conference. Delegates will be refunded the registration fee in full in case the conference gets cancelled from our end.

Substitution Policy:

Substitutions within a company are permitted through the conference date. Shared registrations are not permitted under any circumstances